Astrana targets $72.5M-$77.5M Q3 adjusted EBITDA while raising 2026 adjusted EBITDA to $255M-$280M (NASDAQ:ASTH)


Earnings Call Insights: Astrana Health, Inc. (ASTH) Q2 2026

Management View

  • “Astrana delivered another strong quarter, reflecting continued momentum across the business,” Brandon Sim (President & CEO Brandon Sim) said, highlighting “accelerating demand from payer and provider partners,” “disciplined medical cost trend management,” and “expanding operating leverage driven by our proprietary

Seeking Alpha’s Disclaimer: This article was automatically generated by an AI tool based on content available on the Seeking Alpha website, and has not been curated or reviewed by humans. Due to inherent limitations in using AI-based tools, the accuracy, completeness, or timeliness of such articles cannot be guaranteed. This article is intended for informational purposes only. Seeking Alpha does not take account of your objectives or your financial situation and does not offer any personalized investment advice. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank.



Source link

Charlie Sheen’s Daughter Sami Sheen Reacts to Being Called His “Karma”

Early bitcoin wallet wakes after 15 years with $3.2 million transfer

Leave a Reply

Your email address will not be published. Required fields are marked *